NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology, Application , End Useand Geography
出 版 商：The Insight Partners
出版日期：2019/01/02
頁 數：205頁
文件格式：PDF
價 格：
USD 4,550 (Single-User License)
USD 6,550 (Multi-User License)
USD 8,550 (Global-User License)
USD 6,550 (Multi-User License)
USD 8,550 (Global-User License)
國 家：Global
In the report the NGS based RNA seq market, the market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.
The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market is likely face the restraining factors such as risks related to genetic data and high cost of NGS instruments market. The future trend that is likely to drive the market growth is barcode scanning for long reads sequences.
The NGS based RNA seq market as per the product & services the segment is segmented as sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. The market of sequencing platform has the highest market share in 2018, contributing to NGS based RNA seq market is of 38.3% and is expected to retain its dominance during the forecast period from 2018 to 2027. The sample preparation segment is further sub-segmented into method and workflow step. The method segment further divided as manual and automated. Likewise, the workflow step is sub-segmented as Library preparation & target enrichment, fragmentation, end repair & size selection and quality control. Among the method segment the automated segment is likely to hold the major market in the forecast period. Similarly. The Library preparation & target enrichment among the workflow step segment.
The technology segment of the NGS based RNA seq market includes sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencings. The technology segment for the NGS based RNA seq market was valued at US$ 1,414.59 Mn in 2018 and is estimated to reach US$ 7,984.90 Mn by 2027. The technology segment and is expected to be the fastest growing segment in the forecast period owing advantages of the NGS-based RNA seq offers more sensible and accurate gene expression, the technologies can be applied to any species and these are available in comparatively less price for the various arrays. The companies offering offers various advantages to the researchers through their products. For instance, Illumina, Inc. offer system that uses sequencing by synthesis technology is being widely utilized across the globe for the next generation sequencing. The SBS technology enables the robust performance & maintains the data quality, provides accurate bases and more. Hence, owing to the advantages of the sequencing by synthesis by technology market is likely to propel in the forecast period
Some of the major primary and secondary sources included in the report NGS based RNA seq market are National Institutes of Health, National Science Foundation, Canada foundation for innovation, African Society of Human Genetics, Department of Biotechnology, Dubai Health Authority, Human Heredity and Health in Africa, French National Cancer Institute, Japan Science and Technology Agency, Trinity Translational Medicine Institute and others.
The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market is likely face the restraining factors such as risks related to genetic data and high cost of NGS instruments market. The future trend that is likely to drive the market growth is barcode scanning for long reads sequences.
The NGS based RNA seq market as per the product & services the segment is segmented as sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. The market of sequencing platform has the highest market share in 2018, contributing to NGS based RNA seq market is of 38.3% and is expected to retain its dominance during the forecast period from 2018 to 2027. The sample preparation segment is further sub-segmented into method and workflow step. The method segment further divided as manual and automated. Likewise, the workflow step is sub-segmented as Library preparation & target enrichment, fragmentation, end repair & size selection and quality control. Among the method segment the automated segment is likely to hold the major market in the forecast period. Similarly. The Library preparation & target enrichment among the workflow step segment.
The technology segment of the NGS based RNA seq market includes sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencings. The technology segment for the NGS based RNA seq market was valued at US$ 1,414.59 Mn in 2018 and is estimated to reach US$ 7,984.90 Mn by 2027. The technology segment and is expected to be the fastest growing segment in the forecast period owing advantages of the NGS-based RNA seq offers more sensible and accurate gene expression, the technologies can be applied to any species and these are available in comparatively less price for the various arrays. The companies offering offers various advantages to the researchers through their products. For instance, Illumina, Inc. offer system that uses sequencing by synthesis technology is being widely utilized across the globe for the next generation sequencing. The SBS technology enables the robust performance & maintains the data quality, provides accurate bases and more. Hence, owing to the advantages of the sequencing by synthesis by technology market is likely to propel in the forecast period
Some of the major primary and secondary sources included in the report NGS based RNA seq market are National Institutes of Health, National Science Foundation, Canada foundation for innovation, African Society of Human Genetics, Department of Biotechnology, Dubai Health Authority, Human Heredity and Health in Africa, French National Cancer Institute, Japan Science and Technology Agency, Trinity Translational Medicine Institute and others.
TABLE OF CONTENTS
1. INTRODUCTION 29
1.1 SCOPE OF THE STUDY 29
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 29
2. GLOBAL NGS BASED RNA SEQ MARKET - KEY TAKEAWAYS 31
3. GLOBAL NGS BASED RNA SEQ MARKET - MARKET LANDSCAPE 34
3.1 OVERVIEW 34
3.1.1 Global NGS Based RNA Seq Market - By Product & Services 35
3.1.2 Global NGS Based RNA Seq Market - By Technology 36
3.1.3 Global NGS Based RNA Seq Market - By Application 36
3.1.4 Global NGS Based RNA Seq Market - By End User 36
3.1.5 Global NGS Based RNA Seq Market - By Geography 36
3.2 PEST ANALYSIS 37
3.2.1 North America PEST Analysis 37
3.2.2 Europe PEST Analysis 39
3.2.3 Asia Pacific PEST Analysis 41
3.2.4 Middle East & Africa PEST Analysis 43
3.2.5 South & Central America PEST Analysis 45
4. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET DYNAMICS 47
4.1 KEY MARKET DRIVERS 47
4.1.1 Reduced Cost of Genome Sequencing 47
4.1.2 Advancements in Sequencing Technology 47
4.1.3 Next Generation Sequencing for Cancer 48
4.2 KEY MARKET RESTRAINTS 48
4.2.1 Risks Related to Genetic Data 48
4.2.2 High Cost of NGS Instruments 49
4.3 KEY MARKET OPPORTUNITIES 49
4.3.1 Application of NSG in Biomarker Discovery and Precision Medicine 49
4.3.2 Different Programs for RNA Sequencing 50
4.4 FUTURE TRENDS 50
4.4.1 Barcode Scanning for Long Reads Sequences 50
4.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS 51
5. NGS BASED RNA SEQ MARKET - GLOBAL ANALYSIS 52
5.1 GLOBAL NGS BASED RNA SEQ MARKET REVENUE FORECASTS AND ANALYSIS 52
5.2 GLOBAL NGS BASED RNA SEQ MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 53
5.3 MARKET POSITIONING 54
5.4 PERFORMANCE OF KEY PLAYERS 54
5.4.1 Illumina, Inc. 54
5.4.2 Thermo Fisher Scientific Inc. 55
5.5 EXPERT OPINIONS 55
6. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY PRODUCT & SERVICES 56
6.1 OVERVIEW 56
6.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY PRODUCT & SERVICES, 2018 & 2027 (%) 56
6.3 SAMPLE PREPARATION MARKET 57
6.3.1 Overview 57
6.3.2 Global Sample Preparation Market Revenue and Forecasts to 2027 (US$ Mn) 57
6.3.3 Method Market 58
6.3.3.1 Overview 58
6.3.3.2 Manual Method Market 58
6.3.3.2.1 Overview 58
6.3.3.2.2 Global Manual Method Market Revenue and Forecasts to 2027 (US$ Mn) 59
6.3.3.3 Automated Method Market 60
6.3.3.3.1 Overview 60
6.3.3.3.2 Global Automated Method Market Revenue and Forecasts to 2027 (US$ Mn) 60
6.3.4 Workflow Step Market 61
6.3.4.1 Overview 61
6.3.4.2 Library Preparation & Target Enrichment Market 61
6.3.4.2.1 Overview 61
6.3.4.2.2 Global Library Preparation & Target Enrichment Market Revenue and Forecasts to 2027 (US$ Mn) 62
6.3.4.3 Fragmentation, End Repair & Size Selection Market 63
6.3.4.3.1 Overview 63
6.3.4.3.2 Global Fragmentation, End repair & Size Selection Market Revenue and Forecasts to 2027 (US$ Mn) 63
6.3.4.4 Quality Control Market 64
6.3.4.4.1 Overview 64
6.3.4.4.2 Global Quality Control Market Revenue and Forecasts to 2027 (US$ Mn) 64
6.4 SEQUENCING SERVICES MARKET 65
6.4.1 Overview 65
6.4.2 Global Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn) 66
6.5 SEQUENCING PLATFORM & CONSUMABLES MARKET 67
6.5.1 Overview 67
6.5.2 Global Sequencing Platform & Consumables Market Revenue and Forecasts to 2027 (US$ Mn) 68
6.6 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET 69
6.6.1 Overview 69
6.6.2 Global Data Analysis, Storage & Management Market Revenue and Forecasts to 2027 (US$ Mn) 69
7. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY TECHNOLOGY 70
7.1 OVERVIEW 70
7.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY TECHNOLOGY, 2018 & 2027 (%) 70
7.3 SEQUENCING BY SYNTHESIS (SBS) MARKET 71
7.3.1 Overview 71
7.3.2 Global Sequencing By Synthesis (SBS) Market Revenue and Forecasts to 2027 (US$ Mn) 71
7.4 NANOPORE SEQUENCING MARKET 72
7.4.1 Overview 72
7.4.2 Global Nanopore Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 72
7.5 ION SEMICONDUCTOR SEQUENCING MARKET 73
7.5.1 Overview 73
7.5.2 Global Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 73
7.6 SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET 74
7.6.1 Overview 74
7.6.2 Global Single Molecule Real Time (SMRT) Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 74
8. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY APPLICATION 75
8.1 OVERVIEW 75
8.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY APPLICATION, 2018 & 2027 (%) 75
8.3 DIAGNOSTICS MARKET 76
8.3.1 Overview 76
8.3.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn) 76
8.4 DRUG DISCOVERY MARKET 77
8.4.1 Overview 77
8.4.2 Global Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn) 77
8.5 PRECISION MEDICINE MARKET 78
8.5.1 Overview 78
8.5.2 Global Precision Medicine Market Revenue and Forecasts to 2027 (US$ Mn) 78
8.6 OTHER APPLICATIONS MARKET 79
8.6.1 Overview 79
8.6.2 Global Other Applications Market Revenue and Forecasts to 2027 (US$ Mn) 79
9. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY END USER 80
9.1 OVERVIEW 80
9.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY END USER, 2018 & 2027 (%) 80
9.3 HOSPITALS & CLINICS MARKET 81
9.3.1 Overview 81
9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 81
9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 82
9.4.1 Overview 82
9.4.2 Global Research Centers And Academic & Government Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 82
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 83
9.5.1 Overview 83
9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83
9.6 OTHER END USERS MARKET 84
9.6.1 Overview 84
9.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn) 84
10. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 85
10.1 OVERVIEW 85
10.2 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86
10.3 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
10.3.1 North America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 87
10.3.2 North America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 87
10.4 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
10.5 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
10.6 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
10.7 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89
10.8 US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90
10.8.1 US NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 90
10.8.2 US NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 91
10.8.2.1 US Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 91
10.8.2.2 US Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 91
10.8.3 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 92
10.8.4 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 92
10.8.5 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 93
10.9 CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94
10.9.1 Canada NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 94
10.9.2 Canada NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 95
10.9.2.1 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 95
10.9.2.2 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 95
10.9.3 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 96
10.9.4 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 96
10.9.5 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 97
10.10 MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98
10.10.1 Mexico NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 98
10.10.2 Mexico NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 99
10.10.2.1 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 99
10.10.2.2 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 99
10.10.3 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 100
10.10.4 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 100
10.10.5 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 101
11. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 102
11.1 OVERVIEW 102
11.2 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103
11.3 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
11.3.1 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 104
11.3.2 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 104
11.4 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
11.5 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
11.6 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
11.7 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106
11.8 UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 107
11.8.1 UK NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 108
11.8.2 UK NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 108
11.8.2.1 UK Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 109
11.8.2.2 UK Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 109
11.8.3 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 109
11.8.4 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 110
11.8.5 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 110
11.9 GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111
11.9.1 Germany NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 111
11.9.2 Germany NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 112
11.9.2.1 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 112
11.9.2.2 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 112
11.9.3 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 113
11.9.4 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 113
11.9.5 GERMANY NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 114
11.10 FRANCE NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115
11.10.1 France NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 115
11.10.2 France NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 116
11.10.2.1 France Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 116
11.10.2.2 France Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 116
11.10.3 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 117
11.10.4 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 117
11.10.5 FRANCE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 118
12. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 119
12.1 OVERVIEW 119
12.2 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120
12.3 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
12.3.1 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 121
12.3.2 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 121
12.4 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
12.5 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
12.6 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
12.7 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123
12.8 CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 124
12.8.1 China NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 125
12.8.2 China NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 125
12.8.2.1 China Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 126
12.8.2.2 China Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 126
12.8.3 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 126
12.8.4 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 127
12.8.5 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 127
12.9 INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 128
12.9.1 India NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 129
12.9.2 India NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 129
12.9.2.1 India Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 130
12.9.2.2 India Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 130
12.9.3 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 130
12.9.4 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 131
12.9.5 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 131
12.10 JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132
12.10.1 Japan NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 132
12.10.2 Japan NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 133
12.10.2.1 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 133
12.10.2.2 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 133
12.10.3 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 134
12.10.4 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 134
12.10.5 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 135
13. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 136
13.1 OVERVIEW 136
13.2 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137
13.3 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137
13.3.1 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 138
13.3.2 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 138
13.4 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139
13.5 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139
13.6 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140
13.7 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140
13.8 SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141
13.8.1 Saudi Arabia NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 141
13.8.2 Saudi Arabia NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 142
13.8.2.1 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 142
13.8.2.2 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 142
13.8.3 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 143
13.8.4 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 143
13.8.5 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 144
13.9 UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145
13.9.1 UAE NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 145
13.9.2 UAE NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 146
13.9.2.1 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 146
13.9.2.2 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 146
13.9.3 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 147
13.9.4 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 147
13.9.5 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 148
13.10 SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149
13.10.1 South Africa NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 149
13.10.2 South Africa NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 150
13.10.2.1 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 150
13.10.2.2 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 151
13.10.3 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 151
13.10.4 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 151
13.10.5 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 152
14. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 153
14.1 OVERVIEW 153
14.2 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154
14.3 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154
14.3.1 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 155
14.3.2 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 155
14.4 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156
14.5 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156
14.6 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157
14.7 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157
14.8 BRAZIL BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158
14.8.1 Brazil NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 158
14.8.2 Brazil NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 159
14.8.2.1 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 159
14.8.2.2 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 159
14.8.3 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 160
14.8.4 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 160
14.8.5 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 161
15. NGS-BASED RNA-SEQ MARKET -INDUSTRY LANDSCAPE 162
15.1 OVERVIEW 162
15.2 GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162
15.3 ORGANIC DEVELOPMENTS 162
15.3.1 Overview 162
15.4 ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163
15.5 PRODUCT & SERVICE LAUNCH 163
15.5.1 Recent Product & Service Launch By Players In The NGS-based RNA-seq Market 163
15.6 PRODUCT APPROVAL 164
15.6.1 Recent Product Approval By Players In The NGS-based RNA-seq Market 164
15.7 OTHERS 164
15.7.1 The NGS-based RNA-seq Market By Other Growth Strategies 164
15.8 INORGANIC DEVELOPMENTS 165
15.8.1 Overview 165
15.9 INORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 165
15.10 PARTNERSHIPS 166
15.10.1 Recent Partnerships by Players in the NGS-based RNA-seq Market 166
15.11 COLLABORATIONS 167
15.11.1 Collaborations By Players In The NGS-based RNA-seq Market 167
15.12 EXPANSION 168
15.12.1 The NGS-based RNA-seq Market By Expansion 168
15.13 ACQUISITIONS 169
15.13.1 Acquisitions By Players In The NGS-based RNA-seq Market 169
15.14 AGREEMENTS 169
15.14.1 The NGS-based RNA-seq Market By Agreements 169
16. NGS-BASED RNA-SEQ MARKET-KEY COMPANY PROFILES 170
16.1 ILLUMINA, INC. 170
16.1.1 Key Facts 170
16.1.2 Business Description 170
16.1.3 Financial Overview 171
16.1.4 Product Portfolio 171
16.1.5 Swot Analysis 172
16.1.6 Key Developments 172
16.2 THERMO FISHER SCIENTIFIC INC. 174
16.2.1 Key Facts 174
16.2.2 Business Description 174
16.2.3 Financial Overview 175
16.2.4 Product Portfolio 175
16.2.5 SWOT Analysis 176
16.2.6 Key Developments 176
16.3 PERKINELMER, INC. 177
16.3.1 Key Facts 177
16.3.2 Business Description 177
16.3.3 Financial Overview 178
16.3.4 Product Portfolio 178
16.3.5 SWOT Analysis 179
16.3.6 Key Developments 179
16.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 180
16.4.1 Key Facts 180
16.4.2 Business Description 180
16.4.3 Financial Information 180
16.4.4 Product Portfolio 181
16.4.5 SWOT Analysis 181
16.4.6 Key Developments 181
16.5 F. HOFFMANN-LA ROCHE LTD 182
16.5.1 Key Facts 182
16.5.2 Business Description 182
16.5.3 Financial Information 183
16.5.4 Product Portfolio 183
16.5.5 SWOT Analysis 184
16.5.6 Key Developments 184
16.6 QIAGEN 185
16.6.1 Key Facts 185
16.6.2 Business Description 185
16.6.3 Financial Information 186
16.6.4 Product Portfolio 186
16.6.5 SWOT Analysis 187
16.6.6 Key Developments 188
16.7 AGILENT TECHNOLOGIES 190
16.7.1 Key Facts 190
16.7.2 Business Description 190
16.7.3 Financial Overview 191
16.7.4 Product Portfolio 191
16.7.5 SWOT Analysis 192
16.7.6 Key Developments 192
16.8 BGI 193
16.8.1 Key Facts 193
16.8.2 Business Description 193
16.8.3 Financial Overview 193
16.8.4 Product Portfolio 193
16.8.5 SWOT Analysis 194
16.8.6 Key Developments 194
16.9 OXFORD NANOPORE TECHNOLOGIES 195
16.9.1 Key Facts 195
16.9.2 Business Description 195
16.9.3 Financial Overview 195
16.9.4 Product Portfolio 195
16.9.5 SWOT ANALYSIS 196
16.9.6 Key Developments 196
16.10 EUROFINS SCIENTIFIC 197
16.10.1 Key Facts 197
16.10.2 Business Description 197
16.10.3 Financial Overview 197
16.10.4 Product Portfolio 198
16.10.5 SWOT Analysis 198
16.10.6 Key Developments 198
17. APPENDIX 199
17.1 ABOUT THE INSIGHT PARTNERS 199
17.2 GLOSSARY OF TERMS 200
17.3 METHODOLOGY 202
17.3.1 Coverage 203
17.3.2 Secondary Research 203
17.3.3 Primary Research 204
LIST OF TABLES
TABLE 1. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
TABLE 2. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 87
TABLE 3. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 87
TABLE 4. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
TABLE 5. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
TABLE 6. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
TABLE 7. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 91
TABLE 8. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 91
TABLE 9. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 91
TABLE 10. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 92
TABLE 11. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 92
TABLE 12. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 93
TABLE 13. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 95
TABLE 14. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 95
TABLE 15. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 95
TABLE 16. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 96
TABLE 17. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 96
TABLE 18. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 97
TABLE 19. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 99
TABLE 20. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 99
TABLE 21. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 99
TABLE 22. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 100
TABLE 23. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 100
TABLE 24. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 101
TABLE 25. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
TABLE 26. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 104
TABLE 27. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 104
TABLE 28. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
TABLE 29. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
TABLE 30. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
TABLE 31. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 108
TABLE 32. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 109
TABLE 33. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 109
TABLE 34. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 109
TABLE 35. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 110
TABLE 36. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 110
TABLE 37. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 112
TABLE 38. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 112
TABLE 39. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 112
TABLE 40. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 113
TABLE 41. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 113
TABLE 42. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 114
TABLE 43. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 116
TABLE 44. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 116
TABLE 45. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 116
TABLE 46. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 117
TABLE 47. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 117
TABLE 48. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 118
TABLE 49. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
TABLE 50. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 121
TABLE 51. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 121
TABLE 52. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
TABLE 53. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
TABLE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
TABLE 55. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 125
TABLE 56. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 126
TABLE 57. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 126
TABLE 58. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 126
TABLE 59. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 127
TABLE 60. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 127
TABLE 61. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 129
TABLE 62. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 130
TABLE 63. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 130
TABLE 64. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 130
TABLE 65. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 131
TABLE 66. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 131
TABLE 67. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 133
TABLE 68. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 133
TABLE 69. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (U
1. INTRODUCTION 29
1.1 SCOPE OF THE STUDY 29
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 29
2. GLOBAL NGS BASED RNA SEQ MARKET - KEY TAKEAWAYS 31
3. GLOBAL NGS BASED RNA SEQ MARKET - MARKET LANDSCAPE 34
3.1 OVERVIEW 34
3.1.1 Global NGS Based RNA Seq Market - By Product & Services 35
3.1.2 Global NGS Based RNA Seq Market - By Technology 36
3.1.3 Global NGS Based RNA Seq Market - By Application 36
3.1.4 Global NGS Based RNA Seq Market - By End User 36
3.1.5 Global NGS Based RNA Seq Market - By Geography 36
3.2 PEST ANALYSIS 37
3.2.1 North America PEST Analysis 37
3.2.2 Europe PEST Analysis 39
3.2.3 Asia Pacific PEST Analysis 41
3.2.4 Middle East & Africa PEST Analysis 43
3.2.5 South & Central America PEST Analysis 45
4. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET DYNAMICS 47
4.1 KEY MARKET DRIVERS 47
4.1.1 Reduced Cost of Genome Sequencing 47
4.1.2 Advancements in Sequencing Technology 47
4.1.3 Next Generation Sequencing for Cancer 48
4.2 KEY MARKET RESTRAINTS 48
4.2.1 Risks Related to Genetic Data 48
4.2.2 High Cost of NGS Instruments 49
4.3 KEY MARKET OPPORTUNITIES 49
4.3.1 Application of NSG in Biomarker Discovery and Precision Medicine 49
4.3.2 Different Programs for RNA Sequencing 50
4.4 FUTURE TRENDS 50
4.4.1 Barcode Scanning for Long Reads Sequences 50
4.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS 51
5. NGS BASED RNA SEQ MARKET - GLOBAL ANALYSIS 52
5.1 GLOBAL NGS BASED RNA SEQ MARKET REVENUE FORECASTS AND ANALYSIS 52
5.2 GLOBAL NGS BASED RNA SEQ MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 53
5.3 MARKET POSITIONING 54
5.4 PERFORMANCE OF KEY PLAYERS 54
5.4.1 Illumina, Inc. 54
5.4.2 Thermo Fisher Scientific Inc. 55
5.5 EXPERT OPINIONS 55
6. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY PRODUCT & SERVICES 56
6.1 OVERVIEW 56
6.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY PRODUCT & SERVICES, 2018 & 2027 (%) 56
6.3 SAMPLE PREPARATION MARKET 57
6.3.1 Overview 57
6.3.2 Global Sample Preparation Market Revenue and Forecasts to 2027 (US$ Mn) 57
6.3.3 Method Market 58
6.3.3.1 Overview 58
6.3.3.2 Manual Method Market 58
6.3.3.2.1 Overview 58
6.3.3.2.2 Global Manual Method Market Revenue and Forecasts to 2027 (US$ Mn) 59
6.3.3.3 Automated Method Market 60
6.3.3.3.1 Overview 60
6.3.3.3.2 Global Automated Method Market Revenue and Forecasts to 2027 (US$ Mn) 60
6.3.4 Workflow Step Market 61
6.3.4.1 Overview 61
6.3.4.2 Library Preparation & Target Enrichment Market 61
6.3.4.2.1 Overview 61
6.3.4.2.2 Global Library Preparation & Target Enrichment Market Revenue and Forecasts to 2027 (US$ Mn) 62
6.3.4.3 Fragmentation, End Repair & Size Selection Market 63
6.3.4.3.1 Overview 63
6.3.4.3.2 Global Fragmentation, End repair & Size Selection Market Revenue and Forecasts to 2027 (US$ Mn) 63
6.3.4.4 Quality Control Market 64
6.3.4.4.1 Overview 64
6.3.4.4.2 Global Quality Control Market Revenue and Forecasts to 2027 (US$ Mn) 64
6.4 SEQUENCING SERVICES MARKET 65
6.4.1 Overview 65
6.4.2 Global Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn) 66
6.5 SEQUENCING PLATFORM & CONSUMABLES MARKET 67
6.5.1 Overview 67
6.5.2 Global Sequencing Platform & Consumables Market Revenue and Forecasts to 2027 (US$ Mn) 68
6.6 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET 69
6.6.1 Overview 69
6.6.2 Global Data Analysis, Storage & Management Market Revenue and Forecasts to 2027 (US$ Mn) 69
7. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY TECHNOLOGY 70
7.1 OVERVIEW 70
7.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY TECHNOLOGY, 2018 & 2027 (%) 70
7.3 SEQUENCING BY SYNTHESIS (SBS) MARKET 71
7.3.1 Overview 71
7.3.2 Global Sequencing By Synthesis (SBS) Market Revenue and Forecasts to 2027 (US$ Mn) 71
7.4 NANOPORE SEQUENCING MARKET 72
7.4.1 Overview 72
7.4.2 Global Nanopore Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 72
7.5 ION SEMICONDUCTOR SEQUENCING MARKET 73
7.5.1 Overview 73
7.5.2 Global Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 73
7.6 SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET 74
7.6.1 Overview 74
7.6.2 Global Single Molecule Real Time (SMRT) Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 74
8. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY APPLICATION 75
8.1 OVERVIEW 75
8.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY APPLICATION, 2018 & 2027 (%) 75
8.3 DIAGNOSTICS MARKET 76
8.3.1 Overview 76
8.3.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn) 76
8.4 DRUG DISCOVERY MARKET 77
8.4.1 Overview 77
8.4.2 Global Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn) 77
8.5 PRECISION MEDICINE MARKET 78
8.5.1 Overview 78
8.5.2 Global Precision Medicine Market Revenue and Forecasts to 2027 (US$ Mn) 78
8.6 OTHER APPLICATIONS MARKET 79
8.6.1 Overview 79
8.6.2 Global Other Applications Market Revenue and Forecasts to 2027 (US$ Mn) 79
9. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY END USER 80
9.1 OVERVIEW 80
9.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY END USER, 2018 & 2027 (%) 80
9.3 HOSPITALS & CLINICS MARKET 81
9.3.1 Overview 81
9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 81
9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 82
9.4.1 Overview 82
9.4.2 Global Research Centers And Academic & Government Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 82
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 83
9.5.1 Overview 83
9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83
9.6 OTHER END USERS MARKET 84
9.6.1 Overview 84
9.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn) 84
10. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 85
10.1 OVERVIEW 85
10.2 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86
10.3 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
10.3.1 North America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 87
10.3.2 North America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 87
10.4 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
10.5 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
10.6 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
10.7 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89
10.8 US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90
10.8.1 US NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 90
10.8.2 US NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 91
10.8.2.1 US Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 91
10.8.2.2 US Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 91
10.8.3 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 92
10.8.4 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 92
10.8.5 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 93
10.9 CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94
10.9.1 Canada NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 94
10.9.2 Canada NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 95
10.9.2.1 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 95
10.9.2.2 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 95
10.9.3 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 96
10.9.4 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 96
10.9.5 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 97
10.10 MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98
10.10.1 Mexico NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 98
10.10.2 Mexico NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 99
10.10.2.1 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 99
10.10.2.2 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 99
10.10.3 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 100
10.10.4 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 100
10.10.5 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 101
11. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 102
11.1 OVERVIEW 102
11.2 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103
11.3 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
11.3.1 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 104
11.3.2 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 104
11.4 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
11.5 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
11.6 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
11.7 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106
11.8 UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 107
11.8.1 UK NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 108
11.8.2 UK NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 108
11.8.2.1 UK Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 109
11.8.2.2 UK Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 109
11.8.3 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 109
11.8.4 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 110
11.8.5 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 110
11.9 GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111
11.9.1 Germany NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 111
11.9.2 Germany NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 112
11.9.2.1 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 112
11.9.2.2 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 112
11.9.3 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 113
11.9.4 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 113
11.9.5 GERMANY NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 114
11.10 FRANCE NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115
11.10.1 France NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 115
11.10.2 France NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 116
11.10.2.1 France Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 116
11.10.2.2 France Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 116
11.10.3 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 117
11.10.4 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 117
11.10.5 FRANCE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 118
12. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 119
12.1 OVERVIEW 119
12.2 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120
12.3 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
12.3.1 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 121
12.3.2 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 121
12.4 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
12.5 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
12.6 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
12.7 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123
12.8 CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 124
12.8.1 China NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 125
12.8.2 China NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 125
12.8.2.1 China Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 126
12.8.2.2 China Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 126
12.8.3 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 126
12.8.4 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 127
12.8.5 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 127
12.9 INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 128
12.9.1 India NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 129
12.9.2 India NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 129
12.9.2.1 India Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 130
12.9.2.2 India Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 130
12.9.3 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 130
12.9.4 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 131
12.9.5 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 131
12.10 JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132
12.10.1 Japan NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 132
12.10.2 Japan NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 133
12.10.2.1 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 133
12.10.2.2 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 133
12.10.3 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 134
12.10.4 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 134
12.10.5 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 135
13. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 136
13.1 OVERVIEW 136
13.2 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137
13.3 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137
13.3.1 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 138
13.3.2 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 138
13.4 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139
13.5 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139
13.6 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140
13.7 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140
13.8 SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141
13.8.1 Saudi Arabia NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 141
13.8.2 Saudi Arabia NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 142
13.8.2.1 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 142
13.8.2.2 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 142
13.8.3 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 143
13.8.4 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 143
13.8.5 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 144
13.9 UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145
13.9.1 UAE NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 145
13.9.2 UAE NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 146
13.9.2.1 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 146
13.9.2.2 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 146
13.9.3 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 147
13.9.4 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 147
13.9.5 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 148
13.10 SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149
13.10.1 South Africa NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 149
13.10.2 South Africa NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 150
13.10.2.1 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 150
13.10.2.2 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 151
13.10.3 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 151
13.10.4 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 151
13.10.5 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 152
14. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 153
14.1 OVERVIEW 153
14.2 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154
14.3 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154
14.3.1 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 155
14.3.2 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 155
14.4 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156
14.5 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156
14.6 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157
14.7 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157
14.8 BRAZIL BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158
14.8.1 Brazil NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 158
14.8.2 Brazil NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 159
14.8.2.1 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 159
14.8.2.2 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 159
14.8.3 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 160
14.8.4 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 160
14.8.5 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 161
15. NGS-BASED RNA-SEQ MARKET -INDUSTRY LANDSCAPE 162
15.1 OVERVIEW 162
15.2 GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162
15.3 ORGANIC DEVELOPMENTS 162
15.3.1 Overview 162
15.4 ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163
15.5 PRODUCT & SERVICE LAUNCH 163
15.5.1 Recent Product & Service Launch By Players In The NGS-based RNA-seq Market 163
15.6 PRODUCT APPROVAL 164
15.6.1 Recent Product Approval By Players In The NGS-based RNA-seq Market 164
15.7 OTHERS 164
15.7.1 The NGS-based RNA-seq Market By Other Growth Strategies 164
15.8 INORGANIC DEVELOPMENTS 165
15.8.1 Overview 165
15.9 INORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 165
15.10 PARTNERSHIPS 166
15.10.1 Recent Partnerships by Players in the NGS-based RNA-seq Market 166
15.11 COLLABORATIONS 167
15.11.1 Collaborations By Players In The NGS-based RNA-seq Market 167
15.12 EXPANSION 168
15.12.1 The NGS-based RNA-seq Market By Expansion 168
15.13 ACQUISITIONS 169
15.13.1 Acquisitions By Players In The NGS-based RNA-seq Market 169
15.14 AGREEMENTS 169
15.14.1 The NGS-based RNA-seq Market By Agreements 169
16. NGS-BASED RNA-SEQ MARKET-KEY COMPANY PROFILES 170
16.1 ILLUMINA, INC. 170
16.1.1 Key Facts 170
16.1.2 Business Description 170
16.1.3 Financial Overview 171
16.1.4 Product Portfolio 171
16.1.5 Swot Analysis 172
16.1.6 Key Developments 172
16.2 THERMO FISHER SCIENTIFIC INC. 174
16.2.1 Key Facts 174
16.2.2 Business Description 174
16.2.3 Financial Overview 175
16.2.4 Product Portfolio 175
16.2.5 SWOT Analysis 176
16.2.6 Key Developments 176
16.3 PERKINELMER, INC. 177
16.3.1 Key Facts 177
16.3.2 Business Description 177
16.3.3 Financial Overview 178
16.3.4 Product Portfolio 178
16.3.5 SWOT Analysis 179
16.3.6 Key Developments 179
16.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 180
16.4.1 Key Facts 180
16.4.2 Business Description 180
16.4.3 Financial Information 180
16.4.4 Product Portfolio 181
16.4.5 SWOT Analysis 181
16.4.6 Key Developments 181
16.5 F. HOFFMANN-LA ROCHE LTD 182
16.5.1 Key Facts 182
16.5.2 Business Description 182
16.5.3 Financial Information 183
16.5.4 Product Portfolio 183
16.5.5 SWOT Analysis 184
16.5.6 Key Developments 184
16.6 QIAGEN 185
16.6.1 Key Facts 185
16.6.2 Business Description 185
16.6.3 Financial Information 186
16.6.4 Product Portfolio 186
16.6.5 SWOT Analysis 187
16.6.6 Key Developments 188
16.7 AGILENT TECHNOLOGIES 190
16.7.1 Key Facts 190
16.7.2 Business Description 190
16.7.3 Financial Overview 191
16.7.4 Product Portfolio 191
16.7.5 SWOT Analysis 192
16.7.6 Key Developments 192
16.8 BGI 193
16.8.1 Key Facts 193
16.8.2 Business Description 193
16.8.3 Financial Overview 193
16.8.4 Product Portfolio 193
16.8.5 SWOT Analysis 194
16.8.6 Key Developments 194
16.9 OXFORD NANOPORE TECHNOLOGIES 195
16.9.1 Key Facts 195
16.9.2 Business Description 195
16.9.3 Financial Overview 195
16.9.4 Product Portfolio 195
16.9.5 SWOT ANALYSIS 196
16.9.6 Key Developments 196
16.10 EUROFINS SCIENTIFIC 197
16.10.1 Key Facts 197
16.10.2 Business Description 197
16.10.3 Financial Overview 197
16.10.4 Product Portfolio 198
16.10.5 SWOT Analysis 198
16.10.6 Key Developments 198
17. APPENDIX 199
17.1 ABOUT THE INSIGHT PARTNERS 199
17.2 GLOSSARY OF TERMS 200
17.3 METHODOLOGY 202
17.3.1 Coverage 203
17.3.2 Secondary Research 203
17.3.3 Primary Research 204
LIST OF TABLES
TABLE 1. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
TABLE 2. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 87
TABLE 3. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 87
TABLE 4. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
TABLE 5. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
TABLE 6. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
TABLE 7. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 91
TABLE 8. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 91
TABLE 9. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 91
TABLE 10. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 92
TABLE 11. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 92
TABLE 12. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 93
TABLE 13. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 95
TABLE 14. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 95
TABLE 15. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 95
TABLE 16. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 96
TABLE 17. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 96
TABLE 18. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 97
TABLE 19. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 99
TABLE 20. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 99
TABLE 21. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 99
TABLE 22. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 100
TABLE 23. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 100
TABLE 24. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 101
TABLE 25. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
TABLE 26. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 104
TABLE 27. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 104
TABLE 28. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
TABLE 29. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
TABLE 30. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
TABLE 31. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 108
TABLE 32. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 109
TABLE 33. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 109
TABLE 34. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 109
TABLE 35. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 110
TABLE 36. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 110
TABLE 37. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 112
TABLE 38. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 112
TABLE 39. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 112
TABLE 40. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 113
TABLE 41. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 113
TABLE 42. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 114
TABLE 43. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 116
TABLE 44. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 116
TABLE 45. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 116
TABLE 46. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 117
TABLE 47. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 117
TABLE 48. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 118
TABLE 49. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
TABLE 50. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 121
TABLE 51. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 121
TABLE 52. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
TABLE 53. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
TABLE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
TABLE 55. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 125
TABLE 56. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 126
TABLE 57. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 126
TABLE 58. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 126
TABLE 59. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 127
TABLE 60. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 127
TABLE 61. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 129
TABLE 62. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 130
TABLE 63. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 130
TABLE 64. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 130
TABLE 65. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 131
TABLE 66. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 131
TABLE 67. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 133
TABLE 68. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 133
TABLE 69. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (U
